Dcf Advisers, LLC Amgen Inc Transaction History

Dcf Advisers, LLC

$185 Million
Q2 2024

A detailed history of Dcf Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Dcf Advisers, LLC holds 8,500 shares of AMGN stock, worth $2.72 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

8,500

Previous 10,300 17.48%

Holding current value

$2.72 Million

Previous $2.93 Million 9.32%

% of portfolio

1.44%

Previous 1.49%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $472,950 - $574,758	-1,800 Reduced 17.48%	8,500 $2.66 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $887,271 - $1.07 Million	3,300 Added 47.14%	10,300 $2.93 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $357,980 - $403,844	-1,400 Reduced 16.67%	7,000 $2.02 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.85 Million - $2.3 Million	-8,475 Reduced 50.22%	8,400 $2.26 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $1.47 Million - $1.74 Million	6,875 Added 68.75%	16,875 $3.75 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $2.26 Million - $2.75 Million	10,000 New	10,000 $2.42 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $2.8 Million - $3.09 Million	-12,750 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $298,320 - $341,400	1,500 Added 13.33%	12,750 $2.87 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $117,325 - $130,475	-500 Reduced 4.26%	11,250 $2.86 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $296,715 - $364,110	-1,500 Reduced 11.32%	11,750 $2.77 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $136,680 - $181,275	750 Added 6.0%	13,250 $2.69 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $2.37 Million - $3.04 Million	12,500 New	12,500 $3.01 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account